Therapeutic Use of Extraembryonic-Derived Tissues
<p dir="ltr">Instead as being seen as medical waste, umbilical cord blood (UCB), placenta-derived cells, and other extraembryonic tissue are increasingly accepted as a high-quality source of cells for therapeutic use. The best-known application is the transplantation of hematopoietic...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513513560473600 |
|---|---|
| author | Michael Uhlin (2735023) |
| author2 | Mohamed Abumaree (18628678) Essam M. Abdelalim (5768072) |
| author2_role | author author |
| author_facet | Michael Uhlin (2735023) Mohamed Abumaree (18628678) Essam M. Abdelalim (5768072) |
| author_role | author |
| dc.creator.none.fl_str_mv | Michael Uhlin (2735023) Mohamed Abumaree (18628678) Essam M. Abdelalim (5768072) |
| dc.date.none.fl_str_mv | 2018-06-13T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1155/2018/6082698 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Therapeutic_Use_of_Extraembryonic-Derived_Tissues/25919395 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Medical biotechnology Characterization Regenerative medicine Medical waste Graft source Special edition Research papers Potentiate |
| dc.title.none.fl_str_mv | Therapeutic Use of Extraembryonic-Derived Tissues |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Instead as being seen as medical waste, umbilical cord blood (UCB), placenta-derived cells, and other extraembryonic tissue are increasingly accepted as a high-quality source of cells for therapeutic use. The best-known application is the transplantation of hematopoietic stem cells (HSCT), while UCB has become an increasingly important graft source since UCB transplantation (UCBT) has been implemented in the last 3 decades. Recently, UCB, placenta, and extraembryonic-derived cells and tissues have been also investigated as a source for adoptive cell therapy.</p><p dir="ltr">The nonhematopoietic stem cell types in UCB as well as placenta-derived and extraembryonic cells and tissues include several types that can be used therapeutically and are readily expanded to sufficient numbers using established methods. Most notable of these are mesenchymal stromal cells (MSCs) and endothelial-like vascular progenitors (EPCs). To complicate it further, MSCs from different sources of the placenta seem to have very different properties.</p><p dir="ltr">To even further potentiate the use of extraembryonic-derived tissues for therapy, the sources have to be elaborately characterized. In this special edition, the potential use for this kind of tissues in this was highlighted in several cases illustrating its role in future regenerative medicine. Examples of papers are published in this special edition.</p><h2>Other Information</h2><p dir="ltr">Published in: Stem Cells International<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1155/2018/6082698" target="_blank">https://dx.doi.org/10.1155/2018/6082698</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_26ee3c69d4103f3cf960161627c146cc |
| identifier_str_mv | 10.1155/2018/6082698 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/25919395 |
| publishDate | 2018 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Therapeutic Use of Extraembryonic-Derived TissuesMichael Uhlin (2735023)Mohamed Abumaree (18628678)Essam M. Abdelalim (5768072)Biomedical and clinical sciencesMedical biotechnologyCharacterizationRegenerative medicineMedical wasteGraft sourceSpecial editionResearch papersPotentiate<p dir="ltr">Instead as being seen as medical waste, umbilical cord blood (UCB), placenta-derived cells, and other extraembryonic tissue are increasingly accepted as a high-quality source of cells for therapeutic use. The best-known application is the transplantation of hematopoietic stem cells (HSCT), while UCB has become an increasingly important graft source since UCB transplantation (UCBT) has been implemented in the last 3 decades. Recently, UCB, placenta, and extraembryonic-derived cells and tissues have been also investigated as a source for adoptive cell therapy.</p><p dir="ltr">The nonhematopoietic stem cell types in UCB as well as placenta-derived and extraembryonic cells and tissues include several types that can be used therapeutically and are readily expanded to sufficient numbers using established methods. Most notable of these are mesenchymal stromal cells (MSCs) and endothelial-like vascular progenitors (EPCs). To complicate it further, MSCs from different sources of the placenta seem to have very different properties.</p><p dir="ltr">To even further potentiate the use of extraembryonic-derived tissues for therapy, the sources have to be elaborately characterized. In this special edition, the potential use for this kind of tissues in this was highlighted in several cases illustrating its role in future regenerative medicine. Examples of papers are published in this special edition.</p><h2>Other Information</h2><p dir="ltr">Published in: Stem Cells International<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1155/2018/6082698" target="_blank">https://dx.doi.org/10.1155/2018/6082698</a></p>2018-06-13T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1155/2018/6082698https://figshare.com/articles/journal_contribution/Therapeutic_Use_of_Extraembryonic-Derived_Tissues/25919395CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/259193952018-06-13T03:00:00Z |
| spellingShingle | Therapeutic Use of Extraembryonic-Derived Tissues Michael Uhlin (2735023) Biomedical and clinical sciences Medical biotechnology Characterization Regenerative medicine Medical waste Graft source Special edition Research papers Potentiate |
| status_str | publishedVersion |
| title | Therapeutic Use of Extraembryonic-Derived Tissues |
| title_full | Therapeutic Use of Extraembryonic-Derived Tissues |
| title_fullStr | Therapeutic Use of Extraembryonic-Derived Tissues |
| title_full_unstemmed | Therapeutic Use of Extraembryonic-Derived Tissues |
| title_short | Therapeutic Use of Extraembryonic-Derived Tissues |
| title_sort | Therapeutic Use of Extraembryonic-Derived Tissues |
| topic | Biomedical and clinical sciences Medical biotechnology Characterization Regenerative medicine Medical waste Graft source Special edition Research papers Potentiate |